Research Topic · Peer-Reviewed

Leukaemia

Leukaemia is a group of malignant disorders of the blood-forming tissues in which abnormal white blood cells proliferate uncontrollably in the bone marrow and circulate in the peripheral blood, crowding out normal haematopoiesis. It is classified along two axes: by lineage, into lymphoid (affecting lymphocyte precur…

Curated from this journal's research 📚 10 peer-reviewed articles cited Cited 19× across the literature 🔖 ISSN 2372-6601 🗓 Reviewed July 2026

Overview

Leukaemia is a group of malignant disorders of the blood-forming tissues in which abnormal white blood cells proliferate uncontrollably in the bone marrow and circulate in the peripheral blood, crowding out normal haematopoiesis. It is classified along two axes: by lineage, into lymphoid (affecting lymphocyte precursors) and myeloid (affecting granulocyte, erythroid, and platelet precursors), and by clinical tempo, into acute forms marked by rapid accumulation of immature blasts and chronic forms characterized by more mature but dysfunctional cells. The four principal types are acute lymphoblastic leukaemia, acute myeloid leukaemia, chronic lymphocytic leukaemia, and chronic myeloid leukaemia, with rarer entities such as hairy cell leukaemia. Disease behavior is driven by acquired genetic and chromosomal abnormalities that dysregulate proliferation, differentiation, and apoptosis. Clinical research in this field addresses diagnostic subtyping, complications such as hypercoagulability and impaired clotting in acute disease, metabolic vulnerabilities exploited for targeted therapy, and treatment outcomes including responses to chemotherapy, targeted agents, and stem cell transplantation. Long-term management raises additional concerns, notably medication adherence in chronic disease and supportive care for thrombocytopenia and related cytopenias. Together these dimensions make leukaemia a central focus of haematology and oncology, spanning molecular pathogenesis, accurate classification, and the optimization of curative and palliative strategies.

Research published in this journal

10 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2019

Avant Garde Alleviation -Cancer Immunotherapy

Bajaj AnubhaCorresponding author
MD. (Pathology) Panjab University, Department of Histopathology, A.B. Diagnostics, A-1, Ring Road , Rajouri Garden, New Delhi, 110027, India.
Exact topic Clinical and Diagnostic Pathology doi:10.14302/issn.2689-5773.jcdp-19-3061
2024

Splenectomy Reports

Uluc GünayCorresponding author
Exact topic Spleen And Liver Research doi:10.14302/issn.2578-2371.jslr-24-5157

How this research is being cited

The 10 articles above have been cited 19 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Leukaemia, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Hematology and Oncology Research (ISSN 2372-6601).

Journal editorial board
Jayadev Manikkam Umakanthan · United States Shuaiying Cui · United States Benedetto Sacchetti · Italy

This page summarises published research for orientation; it is not medical or professional advice.